Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Pathologic Complete Response × Irinotecan × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 10 Rectal Neoplasms 4 Colonic Neoplasms 3 Pancreatic Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Stomach Neoplasms 1 Solid Tumors 1 Rhabdomyosarcoma 1 Rare Tumour 1 Pathologic Complete Response 1 Pancreatic Cancer Resectable 1 Neoplasms, Second Primary 1 Medulloblastoma 1 Lung Neoplasms 1 Locally Advanced Low Rectal Adenocarcinoma 1 Esophageal Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Cancer Metastatic 1 Appendiceal Neoplasms 1 Advanced Esophageal Carcinoma 1

Interventions

venetoclax 1 tegafur-gimeracil-oteracil 1 tagraxofusp 1 durvalumab 1 Surgical Procedures, Operative 1 Radiation 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Observation 1 Neoadjuvant Therapy 1 Magnetic Resonance Imaging 1 Leucovorin 1 Irinotecan 1 Induction Chemotherapy 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Folfox protocol 1 Fluorouracil 1 FOLFOXIRI protocol 1 Endoscopy 1 Drug Therapy 1 Colonoscopy 1 Cisplatin 1 Chemoradiotherapy 1 Carboplatin 1 Capecitabine 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡